Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ProteomeTools Part V - TMT labeled non-modified non-tryptic peptides

ABSTRACT: The ProteomeTools project aims to derive molecular and digital tools from the human proteome to facilitate biomedical and life science research. Here, we describe the the generation and multimodal LC-MS/MS analysis of >300,000 synthetic non-tryptic peptides labeled with tandem mass tags (TMT6plex).

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Daniel Zolg

LAB HEAD: Bernhard Kuster

PROVIDER: PXD023120 | Pride | 2021-04-26

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Similar Datasets

ProteomeTools Part IV - TMT labeled non-modified tryptic peptides

2021-01-11 | PXD023119 | Pride

ProteomeTools – Part III - HLA Class I & II & non-tryptic peptides

Project description:The ProteomeTools project aims to derive molecular and digital tools from the human proteome to facilitate biomedical and life science research. Here, we describe the third iteration of the generation and multimodal LC-MS/MS analysis of >305,000 synthetic non-tryptic peptides representing HLA Class I & II ligands as well as peptides derived from the N-terminal proteases LysN and ApsN. This resource will be extended to 1.4 million peptides and all data will be made available to the public in ProteomicsDB.

2021-04-26 | PXD021013 | Pride

ProteomeTools Part IV - TMT labeled non-modified tryptic peptides

2023-04-10 | MSV000091673 | MassIVE

ProteomeTools - Building ProteomeTools based on a complete synthetic human proteome

Project description:The ProteomeTools project aims to derive molecular and digital tools from the human proteome to facilitate biomedical and life science research. Here, we describe the generation and multimodal LC-MS/MS analysis of >350,000 synthetic tryptic peptides representing nearly all canonical human gene products. This resource will be extended to 1.4 million peptides within two years and all data will be made available to the public in ProteomicsDB.

2017-02-09 | PXD004732 | Pride

ProteomeTools – Part II - Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning

Project description:"The ProteomeTools project aims to derive molecular and digital tools from the human proteome to facilitate biomedical and life science research. Here, we describe the second iteration of the generation and multimodal LC-MS/MS analysis of >220,000 synthetic tryptic peptides representing nearly all canonical human gene products. This resource will be extended to 1.4 million peptides and all data will be made available to the public in ProteomicsDB."

2019-05-21 | PXD010595 | Pride

ProteomeTools

Project description:The ProteomeTools project aims to derive molecular and digital tools from the human proteome to facilitate biomedical and life science research. Here, we describe the generation and multimodal LC-MS/MS analysis of >350,000 synthetic tryptic peptides representing nearly all canonical human gene products. This resource will be extended to 1.4 million peptides within two years and all data will be made available to the public in ProteomicsDB.

2017-02-10 | MSV000080544 | MassIVE

ProteomeTools â?? Part II - Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning

2020-07-21 | MSV000085805 | MassIVE

Fragment ion intensity prediction improves the identification rate of non-tryptic peptides in TimsTOF

Project description:Immunopeptidomics plays a crucial role in identifying targets for immunotherapy and vaccine development. Because the generation of immunopeptides from their parent proteins does not adhere to clear-cut rules, rather than being able to use known digestion patterns, every possible protein subsequence within HLA class-specific length restrictions needs to be considered. This leads to an inflation of the search space and results in lower spectrum annotation rates. Rescoring is a powerful enhancement of standard sequence database searching that boosts the spectrum annotation performance. In the field of immunopeptidomics low abundant peptides often occur, which is why the highly sensitive timsTOF instruments are increasingly gaining popularity. To improve rescoring for immunopeptides measured using timsTOF instruments, we trained a deep learning-based fragment ion intensity prediction model. Over 300,000 synthesized non-tryptic peptides from the ProteomeTools project were analyzed on a timsTOF-Pro to generate a dataset that was used to fine-tune an existing Prosit model. By applying our fragment ion intensity prediction model, we demonstrate up to 3-fold improvement in the identification of immunopeptides. Furthermore, our approach increased detection of immunopeptides even from low input samples.

2023-07-17 | MSV000092456 | MassIVE

Building ProteomeTools based on a complete synthetic human proteome.

Project description: Not available

| S-EPMC5868332 | biostudies-literature

Deep learning boosts immunopeptidomics one mass spectrum at a time

Project description:Characterizing the human leukocyte antigen (HLA) bound ligandome by mass spectrometry (MS) holds great promise for developing vaccines and drugs for immune oncology. Still, the identification of such non-tryptic peptides presents substantial computational challenges. To address these, we synthesized >300,000 peptides within the ProteomeTools project representing HLA class I & II ligands and products of the proteases AspN and LysN and analyzed these by multi-modal LC-MS/MS. The resulting data enabled training of a single model using the deep learning framework Prosit that shows outstanding prediction accuracy of fragment ion spectra for tryptic and non-tryptic peptides. Applying Prosit demonstrates that the identification of HLA peptides can be improved by 50-300% on average, that proteasomal HLA peptide splicing may not exist and that additional neo-epitopes that elicit an immune response can be identified from patient tumors. Together, the provided peptides, spectra and computational tools substantially expand the scope of immunopeptidomics workflows.

2021-04-26 | PXD021398 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data